Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Fluoropyrimidine-associated cardiotoxicity: Incidence, clinical manifestations, mechanisms, and management


Wasif M Saif, MD

Professor of Medicine

Tufts University School of Medicine

Director, Gastrointestinal Oncology Program

Leader, Experimental Therapeutics Program

Tufts Medical Center Cancer Center

Jose Banchs, MD, FACC, FASE

Director of Echocardiography

Associate Professor of Medicine

Cardiology Department

University of Texas

MD Anderson Cancer Center

Claus-Henning Köhne, MD

Department of Hematology and Oncology

Onkologie Klinikum Oldenburg

Section Editors

Richard M Goldberg, MD

Section Editor — Gastrointestinal Cancer

Director of the West Virginia University Cancer Institute and the Mary Babb Randolph Cancer Center

Professor of Medicine

Laurence S. & Jean J. DeLynn Chair of Oncology

Juan Carlos Kaski, DSc, MD, DM (Hons), FRCP, FESC, FACC, FAHA

Section Editor — Coronary Heart Disease

Professor of Cardiovascular Science

Director, Cardiovascular and Cell Sciences Research Institute

St. George's, University of London

Deputy Editor

Diane MF Savarese, MD

Senior Deputy Editor — UpToDate

Deputy Editor — Oncology and Palliative Care

Clinical Instructor of Medicine

Harvard Medical School

Peer Reviewer

Reviewers are not identified on topic reviews to preserve anonymity